These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 8017992)

  • 1. High lipoprotein (a) levels as a thrombogenic risk factor in Behçet's disease.
    Orem A; Değer O; Memiş O; Calişkan K; Cimşit G
    Ann Rheum Dis; 1994 May; 53(5):351-2. PubMed ID: 8017992
    [No Abstract]   [Full Text] [Related]  

  • 2. Lipoprotein (a) in Behçet's disease as an indicator of disease activity and in thrombotic complications.
    Gürbüz O; Ozdemir Y; Coşar CB; Kural G
    Eur J Ophthalmol; 2001; 11(1):62-5. PubMed ID: 11284488
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum lipoprotein (a) levels in Behçet's disease.
    Seçkin D; Akpolat T; Oltulu Y; Erkan D; Cantürk T; Adam B; Turanli AY
    Br J Dermatol; 1995 Aug; 133(2):342-3. PubMed ID: 7547422
    [No Abstract]   [Full Text] [Related]  

  • 4. Plasma Lipoprotein(a) and its relationship with disease activity in patients with Behçet's disease.
    Orem A; Değer O; Cimşit G; Karahan SC; Akyol N; Yildirmiş S
    Eur J Clin Chem Clin Biochem; 1995 Aug; 33(8):473-8. PubMed ID: 8547429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lp(a) lipoprotein levels as a predictor of risk for thrombogenic events in patients with Behçet's disease.
    Orem A; Değer O; Memiş O; Bahadir S; Ovali E; Cimşit G
    Ann Rheum Dis; 1995 Sep; 54(9):726-9. PubMed ID: 7495343
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Three risk factors--high lipoprotein (a), elevated FVIII, and FV Leiden--in a pediatric Behçet's disease patient with deep vein thrombosis.
    Gözdaşoğlu S; Uysal Z; Ertem M; Akar N
    Thromb Res; 2002 May; 106(4-5):263. PubMed ID: 12297135
    [No Abstract]   [Full Text] [Related]  

  • 7. Increased plasma lipoprotein (a) concentrations in Behcet's disease and its relation to vascular events.
    Erem C; Uslu T; Deger O; Tosun M; Kavgaci H
    Heart; 2000 Aug; 84(2):208-9. PubMed ID: 10908264
    [No Abstract]   [Full Text] [Related]  

  • 8. Serum lipoprotein (a) levels and Behçet's disease: is there an association?
    Balik O; Gur G; Lenk N; Artuz F; Alli N
    Int J Dermatol; 2007 Aug; 46(8):827-9. PubMed ID: 17651165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thrombophlebitis. A cardinal symptom of Behçet's syndrome.
    Haim S; Sobel JD; Friedman-Birnbaum R
    Acta Derm Venereol; 1974; 54(4):299-301. PubMed ID: 4137316
    [No Abstract]   [Full Text] [Related]  

  • 10. Lipoprotein (a) and nitrites in Behcet's disease: relationship with disease activity and vascular complications.
    Esmat S; El Sherif H; Anwar S; Fahmy I; Elmenyawi M; Shaker O
    Eur J Dermatol; 2006; 16(1):67-71. PubMed ID: 16436346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A case of vasculo-Behcet's syndrome.
    Iwama T; Ishizuka K; Utunomiya J; Shibuya H
    Bull Tokyo Med Dent Univ; 1976 Sep; 23(3):141-7. PubMed ID: 1071429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating endothelial cells in Behçet's disease with cerebral thrombophlebitis.
    Camoin-Jau L; Kone-Paut I; Chabrol B; Sampol J; Dignat-George F
    Thromb Haemost; 2000 Apr; 83(4):631-2. PubMed ID: 10780331
    [No Abstract]   [Full Text] [Related]  

  • 13. [Behçet's disease: a rare cause of recurrent thrombophlebitis].
    Commeau P; Grollier G; de Raucourt S; Gosselin J; Henriet JP; Foucault JP; Potier JC
    LARC Med; 1982; 2(7):562-4. PubMed ID: 7167031
    [No Abstract]   [Full Text] [Related]  

  • 14. Factual or artificial inhibition of fibrinolysis and the occurrence of venous thrombosis in 3 cases of Behçet's disease.
    Kluft C; Michiels JJ; Wijngaards G
    Scand J Haematol; 1980 Nov; 25(5):423-30. PubMed ID: 6452679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platelet function in Behçet's disease.
    Haim S; Brook JG; Gilhar A; Friedman-Birnbaum R; Markel A; Aviram M; Marmur A; Youdin M
    J Dermatol; 1984 Apr; 11(2):117-20. PubMed ID: 6384306
    [No Abstract]   [Full Text] [Related]  

  • 16. Behçet's disease with vascular involvement: the contribution of anticardiolipin antibodies and thrombomodulin.
    Nakano H; Oka H; Matsuda T; Ooka S; Imamura Y; Suzuki T; Yamasaki Y; Itoh G; Azuma K; Ozaki S
    Adv Exp Med Biol; 2003; 528():395-8. PubMed ID: 12918732
    [No Abstract]   [Full Text] [Related]  

  • 17. Treatment of thrombophlebitis of Behçet's disease with low dose cyclosporin A.
    Cantini F; Salvarani C; Niccoli L; Padula A; Arena AI; Bellandi F; Macchioni P; Olivieri I
    Clin Exp Rheumatol; 1999; 17(3):391-2. PubMed ID: 10410282
    [No Abstract]   [Full Text] [Related]  

  • 18. [Thrombophlebitis and arteritis in the pathology of Behcet's syndrome].
    FORMAN L
    Hautarzt; 1960 Aug; 11():363-6. PubMed ID: 13700804
    [No Abstract]   [Full Text] [Related]  

  • 19. Decreased fibrinolysis in Behçet's disease.
    Chajek T; Aronowski E; Izak G
    Thromb Diath Haemorrh; 1973 Jun; 29(3):610-8. PubMed ID: 4761829
    [No Abstract]   [Full Text] [Related]  

  • 20. [Phlebothrombosis of the larger vessels in Behçet's syndrome].
    Holzmann H
    Med Welt; 1965 Aug; 33():1857-8. PubMed ID: 5841663
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.